Disposable Blood Bags Market Size, Share, Growth, and Industry Analysis, By Type (Collection Bags, and Transfer Bags), By Application (Blood Banks, Hospitals, and Non-governmental Organizations (NGOs)), Regional Insights and Forecast From 2026 To 2035

Last Updated: 04 March 2026
SKU ID: 17250284

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

DISPOSABLE BLOOD BAGS MARKET OVERVIEW

The global disposable blood bags market size was estimated at USD 0.37 Billion in 2026 and expected to rise to USD 0.69 Billion by 2035, experiencing a CAGR of 6.9% during the forecast period from 2026 to 2035.

I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.

Download Free Sample

Disposable blood bags serve as medical instruments crafted for the gathering, preservation, conveyance, and transfusion of blood and its constituents. These instruments hold significant importance within the healthcare sector, notably in blood banks, hospitals, and various medical establishments where blood transfusions are carried out.

The primary receptacle for the collection and preservation of blood is typically constructed from flexible plastic materials like PVC (polyvinyl chloride) or other biocompatible plastics. Its purpose is to uphold the integrity of blood components. To prevent clotting and maintain the blood in a liquid state, an anticoagulant solution is introduced into the blood bag. Widely used anticoagulants include CPD (citrate-phosphate-dextrose) or CPDA-1 (citrate-phosphate-dextrose-adenine).

KEY FINDINGS

  • Market Size and Growth: Valued at USD 0.37 billion in 2026, projected to touch USD 0.69 billion by 2035 at a CAGR of 6.9%.
  • Key Market Driver: Around 63% of total demand is driven by rising voluntary blood donation activities worldwide.
  • Major Market Restraint: Nearly 29% of healthcare facilities report biohazard disposal compliance challenges affecting procurement volumes.
  • Emerging Trends: Approximately 34% of manufacturers focus on DEHP-free and eco-friendly blood bag material innovations.
  • Regional Leadership: North America is expected to maintain its position as a major contributor to the global disposable blood bags market, accounting for roughly 35–39%.
  • Competitive Landscape: Top five manufacturers collectively control nearly 48% share of global disposable blood bag supply.
  • Market Segmentation: Collection bags lead with 44%, transfer bags hold 31%, and component bags account for 25%.
  • Recent Development: Around 27% of new product launches emphasize multi-bag systems for enhanced blood component separation efficiency.

COVID-19 IMPACT

Increased Focus on Blood Safety among Population to Fuel Market Growth

The global health crisis has raised awareness regarding the critical need for a secure and resilient blood supply chain. Consequently, there has been a heightened focus on implementing blood safety measures, with an increased emphasis on utilizing disposable blood bags to reduce the potential for contamination and infection.

The global health crisis has caused disturbances in worldwide supply chains, impacting the manufacturing and distribution of medical devices, such as disposable blood bags. This disruption could result in shortages in specific regions, affecting the accessibility of blood bags for healthcare facilities.

LATEST TRENDS

Technological Advancements, Increased Focus on Blood Safety to Drive Market Growth

Manufacturers have been delving into the integration of cutting-edge materials for disposable blood bags. This involves the utilization of specialized plastics like PVC (polyvinyl chloride) and the creation of innovative biocompatible materials that not only adhere to regulatory standards but also elevate the overall functionality of the blood bags. Continuous research is dedicated to enhancing anticoagulant solutions employed in these bags to inhibit clotting and uphold the quality of blood components. Innovations in anticoagulant formulations play a crucial role in prolonging the shelf life of collected blood and ensuring its suitability for transfusions. Increased recognition and focus on adhering to blood safety standards have spurred the need for sophisticated disposable blood bags that comply with rigorous regulatory standards. Manufacturers are actively engaged in creating products that guarantee the integrity and purity of blood products.

  • According to the World Health Organization (WHO), approximately 118.5 million blood donations are collected globally each year, with nearly 40% of donations originating from high-income countries, which represent only about 16% of the global population. WHO further reports that component separation allows one unit of whole blood to be separated into 3 different components (red cells, plasma, and platelets). This trend toward component-based transfusion therapy is increasing demand for multi-bag systems such as double, triple, and quadruple blood bag configurations, which improve storage efficiency and clinical outcomes.
  • According to the Organisation for Economic Co-operation and Development (OECD), member countries perform more than 50 million major surgical procedures annually, many of which require blood transfusion support. Additionally, according to the World Health Organization (WHO), road traffic injuries account for approximately 1.19 million deaths per year, with millions more requiring emergency medical care and transfusion support. This rising volume of surgeries and trauma management cases is contributing to sustained procurement of sterile, single-use blood collection and storage bags in hospitals and blood banks.
Global-Disposable-Blood-Bags-Market-Share,-By-Type,-2035

ask for customizationDownload Free Sample to learn more about this report

DISPOSABLE BLOOD BAGS MARKET SEGMENTATION

By Type

Based on type the global disposable blood bags market can be categorized into Collection Bags, and Transfer Bags.

  • Collection Bags: Collection bags play a pivotal role in the blood donation process by serving as the primary container for collecting blood from donors. Crafted with advanced materials, these bags are engineered to preserve the integrity of collected blood, often integrating features like anticoagulants to prevent clotting. They are essential in maintaining a hygienic and secure environment during blood collection, adhering to rigorous regulatory standards.
  • Transfer Bags: Transfer bags play a crucial role in the isolation and transfer of diverse blood components following collection. Equipped with specialized ports and tubing systems, these bags facilitate the secure and aseptic transfer of elements such as red blood cells, plasma, or platelets. Their design is specifically oriented towards preventing cross-contamination while upholding the purity and quality of each blood constituent, thereby enhancing the overall safety of transfusion procedures.

By Application

Based on application the global disposable blood bags market can be categorized into Blood Banks, Hospitals, and Non-governmental Organizations (NGOs).

  • Blood Banks: Disposable blood bags find significant application in blood banks, serving as a fundamental tool for the collection, storage, and preservation of donated blood. The sterile and single-use characteristics of these bags play a crucial role in ensuring the safe handling of blood, thereby enhancing the operational efficiency of blood banks and ensuring a consistently available and secure blood supply.
  • Hospitals: Within hospital settings, disposable blood bags assume a pivotal role in blood transfusion processes. Utilized for the storage and transportation of blood components, these bags offer healthcare professionals a sanitary and practical means to administer transfusions to patients. The single-use design adheres to infection control protocols prevalent in hospital environments.
  • Non-governmental Organizations (NGOs): Non-governmental Organizations (NGOs) engage in diverse healthcare endeavors such as blood donation campaigns and medical missions. In these contexts, disposable blood bags serve as a pragmatic and sterile option for collecting, transporting, and distributing blood, particularly in resource-limited environments. The single-use feature of these bags is well-suited to address the logistical hurdles frequently encountered by NGOs in remote or emergency situations.

DRIVING FACTORS

Increasing Demand for Blood Transfusions to Boost the Market

The increasing global demand for blood transfusions, propelled by surgical procedures, trauma cases, and medical conditions like anemia, contributes to the disposable blood bags market growth of disposable blood bags in healthcare settings.

Emphasis on Blood Safety to Expand the Market

The increasing awareness and focus on adhering to blood safety standards, particularly in preventing contamination and infection transmission, are key drivers for the adoption of advanced disposable blood bags that meet rigorous regulatory requirements.

  • According to India’s Ministry of Health and Family Welfare, the country operates more than 3,000 licensed blood banks, collectively collecting over 15 million units of blood annually. Furthermore, according to the U.S. Centers for Disease Control and Prevention (CDC), approximately 13.2 million units of whole blood and red blood cells are collected each year in the United States. The expansion of regulated blood banking infrastructure directly increases demand for disposable blood bags, including CPDA-1 and SAGM anticoagulant-based storage systems.
  • According to the World Federation of Hemophilia (WFH), more than 400,000 people worldwide are estimated to be living with hemophilia, many requiring plasma-derived treatments and transfusion support. Additionally, according to the Global Burden of Disease Study referenced by WHO, anemia affects approximately 1.6 billion people globally, particularly women and children. Management of severe anemia cases often involves red blood cell transfusion, thereby increasing the usage frequency of sterile disposable blood collection and storage systems.

RESTRAINING FACTOR

Stringent Regulatory Compliance to Potentially Impede Market Growth

While regulatory standards play a crucial role in ensuring safety, manufacturers may encounter challenges in complying with stringent regulations, including heightened scrutiny, increased testing requirements, and certification processes. These challenges have the potential to impact market entry and operational processes.

  • According to the U.S. Food and Drug Administration (FDA), blood collection systems are regulated as Class II medical devices and must comply with Current Good Manufacturing Practices (cGMP) and detailed quality system regulations under 21 CFR Part 820. Additionally, according to the European Directorate for the Quality of Medicines (EDQM), blood bags must meet sterility assurance levels validated through batch testing, with inspections occurring at defined regulatory intervals. Compliance costs increase due to mandatory validation of shelf life, which typically ranges between 35 to 42 days for stored red blood cells under controlled conditions.
  • According to the World Health Organization (WHO), improper storage and logistical inefficiencies lead to wastage rates ranging between 2% and 6% in various healthcare systems. Red blood cells must be stored at temperatures between 2°C and 6°C, while platelets require storage at 20°C to 24°C with continuous agitation, limiting flexibility in transport and storage. These strict conditions increase operational challenges and can restrict optimal utilization of disposable blood bags in low-resource settings.

DISPOSABLE BLOOD BAGS MARKET REGIONAL INSIGHTS

North America Region Dominating the Market is driven by the well-established regulatory frameworks

North America is expected to maintain its position as a major contributor to the global disposable blood bags market, accounting for roughly 35–39%. Elevated awareness of blood safety standards and robust healthcare infrastructure significantly enhances disposable blood bags market share. The existence of well-established regulatory frameworks ensures strict compliance, thereby fostering the widespread adoption of disposable blood bags. Market expansion is further propelled by continuous technological advancements and the presence of a well-established healthcare system.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through extensive range of healthcare products

Numerous leading companies hold a prominent position in the disposable blood bags market, frequently leading in innovation and playing a substantial role in the market's advancement. One such example is a prominent global medical device company recognized for its extensive range of healthcare products, encompassing blood bags and cutting-edge transfusion-related technologies.

  • Poly Medicure (India): According to company disclosures referenced in filings with India’s Ministry of Corporate Affairs, Poly Medicure manufactures medical devices across more than 120 countries, including blood bag systems. The company operates multiple manufacturing facilities in India with production capacities exceeding 1 billion medical devices annually, including single, double, triple, and quadruple blood bag systems. Its blood collection products are compliant with international standards such as ISO 13485 and CE certification requirements.
  • Grifols (Spain): According to corporate information aligned with data reported to the Spanish National Securities Market Commission (CNMV), Grifols operates plasma collection centers numbering over 390 centers worldwide. The company processes millions of liters of plasma annually and supplies blood-related medical products across more than 100 countries. Grifols invests heavily in transfusion medicine technologies, supporting advanced blood component processing systems that rely on sterile, high-durability disposable blood collection and storage solutions.

List of Top Disposable Blood Bags Companies

  • Poly Medicure (India)
  • Grifols (Spain)
  • Fresenius Kabi (Germany)
  • HLL Lifecare (India)
  • Span Healthcare (U.K.)

INDUSTRIAL DEVELOPMENT

December 2023: The disposable blood bags market is anticipated to experience significant growth in the forecast period on a global scale. Key drivers include the rising incidence of chronic diseases, advancements in technology, and governmental efforts to encourage safe blood transfusion practices, collectively propelling the expansion of the market.

REPORT COVERAGE

The future demand for disposable blood bags market is covered in this study. The Research report includes the Increased Focus on Blood Safety due to the Covid-19 Impact. The report covers the latest trends in Technological Advancements. The paper includes a segmentation of the disposable blood bags market. The research paper includes the driving factors that are Increasing Demand for Blood Transfusions to Fuel Market Growth. The report also covers information on Regional Insights where the region which has emerged leading market for disposable blood bags.

Disposable Blood Bags Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.37 Billion in 2026

Market Size Value By

US$ 0.69 Billion by 2035

Growth Rate

CAGR of 6.9% from 2026 to 2035

Forecast Period

2026-2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Collection Bags
  • Transfer Bags

By Application

  • Blood Banks
  • Hospitals
  • Non-governmental Organizations (NGOs)

FAQs

Stay Ahead of Your Rivals Get instant access to complete data, competitive insights, and decade-long market forecasts. Download FREE Sample